Contact: email@example.com Direct phone: 503-757-8444
NEWS & VIEWS
APeX Institute Press Release for London Invitation.
Oregon State Department of Justice
Twelve Month Investigation
( ODJ - CASE NO. XCT0030-11)
On August 15th, 2011, due to a formal complaint against APeX Institute, the Oregon State Department of Justice began a formal investigation of APeX Global Disease Research Institute and Director Bill Chastain. After intense twelve month legal enquiries directed at the APeX Research Team and our ICAM Study Volunteers, the DOJ returned a finding of no wrong doing, giving us a clean bill of health - a victory for APeX Institute and for our many volunteers.
Invitation to be Key Note Speakers at the prestigious International
Advanced Cancer Diagnostic and Therapy Congress in London.
Hypoxic Micro-Environments may be the Primary Driver of Uncontrollable Tumor Growth;
1. Hypoxia induced changes in cancer cells can increase resistance to conventional therapies.
2. With Hypoxia identified as a key driver for the growth and spread of cancer (Merck Drugs - 2011), APeX Direct Cellular Oxygen Infusion appears to be an effective break-through therapy.
3. APeX Autonomous Oxygen Delivery Nano-Clusters deliver active oxygen molecules directly into the cancer cells hypoxic micro-environment, dramatically reducing or eliminating the hypoxic condition in which cancer cells thrive.